{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T01:40:01Z","timestamp":1773020401011,"version":"3.50.1"},"reference-count":40,"publisher":"Georg Thieme Verlag KG","issue":"03","funder":[{"name":"Chengdu Medical Research Project","award":["2022554"],"award-info":[{"award-number":["2022554"]}]},{"DOI":"10.13039\/501100018542","name":"Natural Science Foundation of Sichuan","doi-asserted-by":"crossref","award":["2022NSFSC0740"],"award-info":[{"award-number":["2022NSFSC0740"]}],"id":[{"id":"10.13039\/501100018542","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Horm Metab Res"],"published-print":{"date-parts":[[2025,3]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>The relationship between serum circCSPP1, circNIPSNAP3A, or circRFX8 and the\n                    occurrence and severity of non-alcoholic fatty liver disease (NAFLD) has yet to\n                    be fully elucidated. A total of 494 participants were divided into NAFLD and\n                    control groups, and clinical data, including demographic, physiological and\n                    biochemical parameters, were collected. Serum levels of circCSPP1,\n                    circNIPSNAP3A, and circRFX8 were measured using quantitative real-time PCR, and\n                    the severity of NAFLD was assessed by ultrasonography and quantitative computed\n                    tomography. The NAFLD group exhibited significantly higher levels of serum\n                    circCSPP1 compared to the control group (p=0.04). CircCSPP1 is significantly and\n                    independently associated with NAFLD. Participants with high serum circCSPP1\n                    levels (&gt;66th percentile) had a greater prevalence of mild and advanced\n                    NAFLD, as well as higher triglyceride levels, compared to those with low\n                    circCSPP1 levels (&lt;33rd percentile) (p&lt;0.05 for all). No significant\n                    correlations were observed between circNIPSNAP3A or circRFX8 and the occurrence\n                    or severity of NAFLD. These findings suggest that serum circCSPP1 is associated\n                    with the occurrence and severity of NAFLD, potentially mediated by\n                    hypertriglyceridemia.<\/jats:p>","DOI":"10.1055\/a-2532-4370","type":"journal-article","created":{"date-parts":[[2025,3,7]],"date-time":"2025-03-07T00:03:51Z","timestamp":1741305831000},"page":"208-215","source":"Crossref","is-referenced-by-count":1,"title":["Serum CircCSPP1 is Correlated with the Occurrence and Severity of\n                    NAFLD in a Chinese Population"],"prefix":"10.1055","volume":"57","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6886-0873","authenticated-orcid":false,"given":"Yongyan","family":"Song","sequence":"additional","affiliation":[{"name":"Central Laboratory, Clinical Medical College & Affiliated Hospital\n                    of Chengdu University, Chengdu, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xue","family":"Wang","sequence":"additional","affiliation":[{"name":"Central Laboratory, Clinical Medical College & Affiliated Hospital\n                    of Chengdu University, Chengdu, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jia","family":"Pan","sequence":"additional","affiliation":[{"name":"Department of Health Management Center, Clinical Medical College &\n                    Affiliated Hospital of Chengdu University, Chengdu, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ting","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Urology Surgery, Clinical Medical College &\n                    Affiliated Hospital of Chengdu University, Chengdu, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yang","family":"Wu","sequence":"additional","affiliation":[{"name":"Clinical Medical College, Chengdu University, Chengdu,\n                    China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qianyin","family":"Pang","sequence":"additional","affiliation":[{"name":"Clinical Medical College, Chengdu University, Chengdu,\n                    China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Youjin","family":"Zhang","sequence":"additional","affiliation":[{"name":"Central Laboratory, Clinical Medical College & Affiliated Hospital\n                    of Chengdu University, Chengdu, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yunhan","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Urology Surgery, Clinical Medical College &\n                    Affiliated Hospital of Chengdu University, Chengdu, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jin","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Urology Surgery, Clinical Medical College &\n                    Affiliated Hospital of Chengdu University, Chengdu, China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"194","published-online":{"date-parts":[[2025,3,6]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1097\/HEP.0000000000000004","article-title":"The global epidemiology of nonalcoholic fatty liver disease (NAFLD) and\n                    nonalcoholic steatohepatitis (NASH): a systematic review","volume":"77","author":"Z M Younossi","year":"2023","journal-title":"Hepatology"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1016\/j.jhep.2023.04.036","article-title":"Changing epidemiology, global trends and implications for outcomes of NAFLD","volume":"79","author":"V W Wong","year":"2023","journal-title":"J Hepatol"},{"key":"ref3","first-page":"e0251","article-title":"The burden of nonalcoholic fatty liver disease (NAFLD) is rapidly growing in\n                    every region of the world from 1990 to 2019","volume":"7","author":"J M Paik","year":"2023","journal-title":"Hepatol Commun"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"639548","DOI":"10.3389\/fendo.2021.639548","article-title":"Non-alcoholic fatty liver disease in obese youth with insulin resistance and\n                    type 2 diabetes","volume":"12","author":"S Scapaticci","year":"2021","journal-title":"Front Endocrinol (Lausanne)"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"957","DOI":"10.3390\/microorganisms9050957","article-title":"Gut microbiota and NAFLD: pathogenetic mechanisms, microbiota signatures, and\n                    therapeutic interventions","volume":"9","author":"T Hrncir","year":"2021","journal-title":"Microorganisms"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1186\/s12943-020-01286-3","article-title":"Circular RNA: metabolism, functions and interactions with proteins","volume":"19","author":"W Y Zhou","year":"2020","journal-title":"Mol Cancer"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1507\/endocrj.EJ24-0008","article-title":"Inhibition of mmu_circ_0009303 improves metabolic dysfunction-associated\n                    steatotic liver disease by regulating lipid metabolism and oxidative stress","volume":"72","author":"J Zhou","year":"2025","journal-title":"Endocr J"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"G485","DOI":"10.1152\/ajpgi.00255.2023","article-title":"Circular RNA RRM2 alleviates metabolic dysfunction-associated steatotic liver\n                    disease by targeting miR-142-5p to increase NRG1 expression","volume":"327","author":"L F Wu","year":"2024","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"ref9","first-page":"10","article-title":"Investigating the role of non-coding RNA in non-alcoholic fatty liver disease.\n                    Noncoding","volume":"10","author":"S A Zailaie","year":"2024","journal-title":"RNA"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"1035159","DOI":"10.3389\/fendo.2022.1035159","article-title":"Discussing the role of circular RNA in the pathogenesis of non-alcoholic fatty\n                    liver disease and its complications","volume":"13","author":"M Yepmo","year":"2022","journal-title":"Front Endocrinol (Lausanne)"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"940","DOI":"10.3390\/biom13060940","article-title":"Overview of circRNAs roles and mechanisms in liver fibrosis","volume":"13","author":"G Wang","year":"2023","journal-title":"Biomolecules"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1186\/s12964-023-01051-1","article-title":"CircRNAs: versatile players and new targets in organ fibrosis","volume":"21","author":"L Wei","year":"2023","journal-title":"Cell Commun Signal"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"1389329","DOI":"10.3389\/fmed.2024.1389329","article-title":"The role of PI3k\/AKT signaling pathway in attenuating liver fibrosis: a\n                    comprehensive review","volume":"11","author":"E Shamsan","year":"2024","journal-title":"Front Med (Lausanne)"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1620\/tjem.2024.J023","article-title":"Serum circNIPSNAP3A is associated with metabolic disorders, atherosclerosis and\n                    severity of coronary artery disease in a Chinese population","volume":"263","author":"X Wang","year":"2024","journal-title":"Tohoku J Exp Med"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"e3001538","DOI":"10.1371\/journal.pbio.3001538","article-title":"RFX transcription factors control a miR-150\/PDAP1 axis that restrains the\n                    proliferation of human T cells","volume":"20","author":"M Chirichella","year":"2022","journal-title":"PLoS Biol"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1038\/s41436-021-01114-z","article-title":"Disruption of RFX family transcription factors causes autism,\n                    attention-deficit\/hyperactivity disorder, intellectual disability, and\n                    dysregulated behavior","volume":"23","author":"H K Harris","year":"2021","journal-title":"Genet Med"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1186\/s12967-024-05562-4","article-title":"CircRNA as an Achilles heel of cancer: characterization, biomarker and\n                    therapeutic modalities","volume":"22","author":"J Zhang","year":"2024","journal-title":"J Transl Med"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1038\/s41419-021-03743-3","article-title":"CircRNAs: role in human diseases and potential use as biomarkers","volume":"12","author":"L Verduci","year":"2021","journal-title":"Cell Death Dis"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"884037","DOI":"10.3389\/fgene.2022.884037","article-title":"Profile analysis and functional modeling identify circular RNAs in nonalcoholic\n                    fatty liver disease as regulators of hepatic lipid metabolism","volume":"13","author":"Y Xie","year":"2022","journal-title":"Front Genet"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1186\/s12951-021-01108-8","article-title":"A nanodrug system overexpressed circRNA_0001805 alleviates nonalcoholic fatty\n                    liver disease via miR-106a-5p\/miR-320a and ABCA1\/CPT1 axis","volume":"19","author":"J Li","year":"2021","journal-title":"J Nanobiotechnol"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1186\/s12967-022-03240-x","article-title":"Circular RNA circCSPP1 promotes the occurrence and development of colon cancer\n                    by sponging miR-431 and regulating ROCK1 and ZEB1","volume":"20","author":"J Wang","year":"2022","journal-title":"J Transl Med"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"5335","DOI":"10.1172\/JCI63562","article-title":"Rho-kinase\/AMPK axis regulates hepatic lipogenesis during overnutrition","volume":"128","author":"H Huang","year":"2018","journal-title":"J Clin Invest"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"116829","DOI":"10.1016\/j.lfs.2019.116829","article-title":"LncRNA NEAT1 promotes hepatic lipid accumulation via regulating\n                    miR-146a-5p\/ROCK1 in nonalcoholic fatty liver disease","volume":"235","author":"X Chen","year":"2019","journal-title":"Life Sci"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"110190","DOI":"10.1016\/j.cellsig.2021.110190","article-title":"LncRNA HOTAIR regulates the lipid accumulation in non-alcoholic fatty liver\n                    disease via miR-130b-3p\/ROCK1 axis","volume":"90","author":"B Guo","year":"2022","journal-title":"Cell Signal"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1038\/s41419-021-04090-z","article-title":"Circ_0057558 promotes nonalcoholic fatty liver disease by regulating ROCK1\/AMPK\n                    signaling through targeting miR-206","volume":"12","author":"X Chen","year":"2021","journal-title":"Cell Death Dis"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/s13065-023-01081-3","article-title":"Discovery of dual rho-associated protein kinase 1 (ROCK1)\/apoptosis\n                    signal-regulating kinase 1 (ASK1) inhibitors as a novel approach for\n                    non-alcoholic steatohepatitis (NASH) treatment","volume":"18","author":"Y A Zaky","year":"2024","journal-title":"BMC Chem"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1016\/j.omtn.2021.10.006","article-title":"HnRNP-L-regulated circCSPP1\/miR-520h\/EGR1 axis modulates autophagy and promotes\n                    progression in prostate cancer","volume":"26","author":"J Lu","year":"2021","journal-title":"Mol Ther Nucleic Acids"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"100724","DOI":"10.1016\/j.jhepr.2023.100724","article-title":"Zinc finger transcription factor Egf1 promotes non-alcoholic fatty liver\n                    disease","volume":"5","author":"Y Guo","year":"2023","journal-title":"JHEP Rep"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.jhep.2011.03.019","article-title":"Cdc42 and Rac1 are major contributors to the saturated fatty acid-stimulated JNK\n                    pathway in hepatocytes","volume":"56","author":"M Sharma","year":"2012","journal-title":"J Hepatol"},{"key":"ref30","first-page":"693","article-title":"Circular RNA CSPP1 motivates renal cell carcinoma carcinogenesis and the Warburg\n                    effect by targeting RAC1 through microRNA-493-5p","volume":"70","author":"D Zhang","year":"2023","journal-title":"Acta Biochim Pol"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1186\/s12864-018-4564-6","article-title":"Characterization of the human RFX transcription factor family by regulatory and\n                    target gene analysis","volume":"19","author":"D Sugiaman-Trapman","year":"2018","journal-title":"BMC Genomics"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"1249070","DOI":"10.3389\/fendo.2023.1249070","article-title":"Minor alleles of FTO rs9939609 and rs17817449 polymorphisms confer a higher risk\n                    of type 2 diabetes mellitus and dyslipidemia, but not coronary artery disease in\n                    a Chinese Han population","volume":"14","author":"Y Zhang","year":"2023","journal-title":"Front Endocrinol (Lausanne)"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"1210455","DOI":"10.3389\/fendo.2023.1210455","article-title":"The rs17782313 polymorphism near MC4R gene confers a high risk of obesity and\n                    hyperglycemia, while PGC1\u03b1 rs8192678 polymorphism is weakly correlated with\n                    glucometabolic disorder: a systematic review and meta-analysis","volume":"14","author":"Y Zhang","year":"2023","journal-title":"Front Endocrinol (Lausanne)"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"2643","DOI":"10.3390\/nu15122643","article-title":"Polymorphisms of fat mass and obesity-associated gene in the pathogenesis of\n                    child and adolescent metabolic syndrome","volume":"15","author":"Y Song","year":"2023","journal-title":"Nutrients"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1136\/postgradmedj-2021-140354","article-title":"rs10865710 polymorphism in PPARG promoter is associated with the severity of\n                    type 2 diabetes mellitus and coronary artery disease in a Chinese\n                    population","volume":"98","author":"Y Song","year":"2022","journal-title":"Postgrad Med J"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1055\/a-2043-7707","article-title":"C Allele of the PPAR\u03b4+294T>C polymorphism confers a higher risk of\n                    hypercholesterolemia, but not obesity and insulin resistance: a systematic\n                    review and meta-analysis","volume":"55","author":"S Li","year":"2023","journal-title":"Horm Metab Res"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"919087","DOI":"10.3389\/fendo.2022.919087","article-title":"G Allele of the rs1801282 polymorphism in PPAR\u03b3 gene confers an increased risk\n                    of obesity and hypercholesterolemia, while T allele of the rs3856806\n                    polymorphism displays a protective role against dyslipidemia: a systematic\n                    review and meta-analysis","volume":"13","author":"S Li","year":"2022","journal-title":"Front Endocrinol (Lausanne)"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"808929","DOI":"10.3389\/fcvm.2022.808929","article-title":"PPAR\u03b3 Gene polymorphisms, metabolic disorders, and coronary artery disease","volume":"9","author":"Y Song","year":"2022","journal-title":"Front Cardiovasc Med"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1159\/000514076","article-title":"The association between COMT Val158Met polymorphism and the post-traumatic\n                    stress disorder risk: a meta-analysis","volume":"81","author":"M Su","year":"2022","journal-title":"Neuropsychobiology"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1055\/a-1543-6362","article-title":"Associations of the polymorphisms in ADIPOQ with circulating levels of\n                    adiponectin and lipids: a meta-analysis","volume":"53","author":"M Su","year":"2021","journal-title":"Horm Metab Res"}],"container-title":["Hormone and Metabolic Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.thieme-connect.de\/products\/ejournals\/pdf\/10.1055\/a-2532-4370.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,7]],"date-time":"2025-03-07T00:06:13Z","timestamp":1741305973000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.thieme-connect.de\/DOI\/DOI?10.1055\/a-2532-4370"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":40,"journal-issue":{"issue":"03","published-online":{"date-parts":[[2025,3,6]]},"published-print":{"date-parts":[[2025,3]]}},"URL":"https:\/\/doi.org\/10.1055\/a-2532-4370","archive":["Portico","CLOCKSS"],"relation":{},"ISSN":["0018-5043","1439-4286"],"issn-type":[{"value":"0018-5043","type":"print"},{"value":"1439-4286","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3]]}}}